Prostate Cancer Trial, Recruiting NCT06776172 Sponsor: University Hospital, Basel, Switzerland Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06776172
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older with a life expectancy of more than 15 years
  • People with prostate cancer confirmed by biopsy, classified as WHO/ISUP grade group III, IV, or V
  • People with high-risk prostate cancer, which includes either a biopsy-confirmed WHO/ISUP grade group III–V, or grade group II with a PSA level above 20 ng/ml
  • People whose PSMA-PET scan shows no signs of cancer spread to nearby lymph nodes or distant parts of the body
  • People for whom a specialist medical team has recommended surgical removal of the prostate (radical prostatectomy)
  • People in good general health, rated as WHO performance status 0 or 1 (meaning fully active or able to carry out light activity)
  • People whose overall health is suitable for general anaesthesia and major surgery (rated ASA III or lower) (confirm with trial site)

Who may not be able to join:

  • People with the lowest-risk prostate cancer classification (ISUP grade group I) and early-stage disease on MRI scan (cT1 or cT2)
  • People whose MRI scan shows the cancer has grown beyond the prostate into nearby structures (cT4 stage)
  • People whose PSMA-PET scan shows cancer has spread to nearby or distant areas of the body
  • People who have already received any treatment for prostate cancer, including hormone therapy, radiation, or other systemic or local treatments
  • People who have previously had lymph node removal in the pelvic area or radiation treatment to the pelvis
  • People who have had another type of cancer in the past, unless that cancer was fully treated at least 2 years before joining the trial and there is no current sign of that cancer returning (a shorter time may be acceptable for cancers that are unlikely to come back — confirm with trial site)
  • People with serious medical, mental health, psychological, family, or practical circumstances that, in the opinion of the medical team, could interfere with treatment, follow-up, or safety
  • People who are not able to make their own informed decisions, or who are under legal guardianship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 61 26 87122

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Basel, Switzerland
Registry
ClinicalTrials.gov
Start date
10 February 2025
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Prostate specific antigen (PSA) persistence; Biochemical recurrence free survival (BCRFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov